A REVOLUTIONARY APPROACH WITH A GAME-CHANGING TECHNOLOGY
All-ScaleFlow™-based-equipment allows to produce mRNA vaccines and therapeutics faster, all over the world, at any scale!
Doses
Minimum scale
Doses
Annual capacity
Only
Equipment footprint
PARTNERS
They trust us
NEWS
Dillico Grand Prix i-Lab 2023
Dillico Grand Prix i-Lab 2023 (English version below) Nous sommes honorés d'avoir été choisis parmi de nombreux candidats exceptionnels, comme lauréat du Grand prix i-Lab 2023 ! Ce prix revêt une importance particulière car [...]
Afrigen Biologics and Dillico sign CRADA to advance mRNA manufacturing solutions
Afrigen Biologics, the development lead in the mRNA technology transfer programme and Dillico Announce Cooperative R&D Agreement to test a new continuous mRNA Manufacturing Solution adapted for low- and middle-income countries. Cape Town, [...]
Flora Binder to join Dillico as Chief Development Officer
We are pleased to announce today that Flora Binder has taken up her role of Dillico’s Chief Development Officer. “Flora has a solid expertise in mRNA process transfer in the global pharmaceutical industry and it will be a significant asset to Dillico to advance our [...]